Search results
- 1.0584844 - ÚMG 2025 RIV GB eng J - Journal Article
Turková, T. - Kokavec, J. - Zikmund, T. - Dibus, Nikol - Pimková, K. - Němec, D. - Holečková, M. - Rusková, L. - Sedláček, Radislav - Čermák, Lukáš - Stopka, T.
Differential requirements for Smarca5 expression during hematopoietic stem cell commitment.
Communications Biology. Roč. 7, č. 1 (2024), č. článku 244. E-ISSN 2399-3642
R&D Projects: GA MZd NU22-05-00374; GA MZd NU21-08-00312; GA MŠMT LX22NPO5102; GA MŠMT(CZ) LM2018126; GA MŠMT LM2023036; GA MŠMT EF16_013/0001789; GA MŠMT EF18_046/0015861; GA ČR(CZ) GA24-10435S
Institutional support: RVO:68378050
Keywords : iswi * mice * mechanisms * snf2h
OECD category: Hematology
Impact factor: 5.9, year: 2022
Method of publishing: Open access
https://www.nature.com/articles/s42003-024-05917-z
Permanent Link: https://hdl.handle.net/11104/0352849 - 2.0571759 - ÚMG 2024 RIV CH eng J - Journal Article
Kuželová, Andrea - Dupačová, Naoko - Antošová, Barbora - Sunny, Sweetu Susan - Kozmik Jr, Zbyněk - Pačes, Jan - Skoultchi, A. - Stopka, T. - Kozmik, Zbyněk
Chromatin Remodeling Enzyme Snf2h Is Essential for Retinal Cell Proliferation and Photoreceptor Maintenance.
Cells. Roč. 12, č. 7 (2023), č. článku 1035. E-ISSN 2073-4409
R&D Projects: GA ČR GA21-27364S; GA MZd NU22-05-00374; GA MŠMT LX22NPO5102
Institutional support: RVO:68378050
Keywords : Snf2h * Smarca5 * retina * photoreceptors * cell cycle * apoptosis
OECD category: Biochemistry and molecular biology
Impact factor: 6, year: 2022
Method of publishing: Open access
https://www.mdpi.com/2073-4409/12/7/1035
Permanent Link: https://hdl.handle.net/11104/0343046File Download Size Commentary Version Access cells-kuzelova-23.pdf 0 21.9 MB Publisher’s postprint open-access - 3.0557510 - ÚMG 2023 RIV CH eng J - Journal Article
Minařík, L. - Pimková, K. - Kokavec, J. - Schaffartzikova, A. - Vellieux, F. - Kulvait, V. - Daumová, L. - Dusilkova, N. - Jonasova, A. - Vargova, K. - Králová Viziová, Petra - Sedláček, Radislav - Zemanová, Z. - Stopka, T.
Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways.
Cells. Roč. 11, č. 2 (2022), č. článku 223. E-ISSN 2073-4409
R&D Projects: GA MŠMT(CZ) LM2018126; GA ČR(CZ) GA19-03586S
Institutional support: RVO:68378050
Keywords : myelodysplastic syndrome * Azacytidine * resistance * CDX mice * pi3k * AKT signaling
OECD category: Cell biology
Impact factor: 6, year: 2022
Method of publishing: Open access
https://www.mdpi.com/2073-4409/11/2/223
Permanent Link: http://hdl.handle.net/11104/0331474 - 4.0531962 - ÚMG 2021 RIV US eng J - Journal Article
Přibyl, Miroslav - Hubáčková, Soňa - Moudrá, Alena - Vančurová, Markéta - Polackova, H. - Stopka, T. - Jonasova, A. - Bokorova, R. - Fuchs, O. - Stříteský, J. - Šalovská, Barbora - Bártek, Jiří - Hodný, Zdeněk
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes.
Molecular Oncology. Roč. 14, č. 10 (2020), s. 2403-2419. ISSN 1574-7891. E-ISSN 1878-0261
R&D Projects: GA ČR(CZ) GA17-07635S; GA MŠMT(CZ) ED1.1.00/02.0109
Institutional support: RVO:68378050
Keywords : 5-azacytidine * biomarker * mds * MDSCs * suprabasin
OECD category: Hematology
Impact factor: 6.603, year: 2020
Method of publishing: Open access
https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12768
Permanent Link: http://hdl.handle.net/11104/0310586 - 5.0518837 - ÚEM 2020 RIV US eng J - Journal Article
Zikmund, T. - Kokavec, J. - Turková, T. - Savvulidi, F. - Paszeková, H. - Vodenková, Soňa - Sedláček, Radislav - Skoultchi, A. - Stopka, T.
ISWI ATPase Smarca5 Regulates Differentiation of Thymocytes Undergoing beta-Selection.
Journal of Immunology. Roč. 202, č. 12 (2019), s. 3434-3446. ISSN 0022-1767. E-ISSN 1550-6606
R&D Projects: GA MŠMT(CZ) LM2015040; GA MŠMT(CZ) LQ1604; GA MŠMT ED2.1.00/19.0395; GA MŠMT(CZ) ED1.1.00/02.0109; GA ČR(CZ) GA19-10543S; GA MZd(CZ) NV17-30920A; GA MŠMT ED2.1.00/19.0395
Institutional support: RVO:68378041 ; RVO:68378050
Keywords : chromatin-remodeling complexes * DNA-damage * lymphocyte development
OECD category: Human genetics; Human genetics (UMG-J)
Impact factor: 4.886, year: 2019
Method of publishing: Open access with time embargo
https://www.jimmunol.org/content/202/12/3434
Permanent Link: http://hdl.handle.net/11104/0303868File Download Size Commentary Version Access Journal_of_Immunology_T_Zikmund_2019.pdf 3 4.5 MB Publisher’s postprint require - 6.0506807 - ÚMG 2020 RIV GB eng J - Journal Article
Jonasova, A. - Neuwirtová, R. - Polackova, H. - Šišková, M. - Stopka, T. - Cmunt, E. - Belickova, M. - Moudrá, Alena - Minařík, L. - Fuchs, O. - Michalová, K. - Zemanová, Z.
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin +/- prednisone addition to lenalidomide in refractory or relapsed patients).
Leukemia Research. Roč. 69, June (2018), s. 12-17. ISSN 0145-2126. E-ISSN 1873-5835
Institutional support: RVO:68378050
Keywords : Myelodysplastic syndromes * Lenalidomide * Del(5q) aberration * Erythropoietin * Prednisone
OECD category: Cell biology
Impact factor: 2.066, year: 2018
Method of publishing: Limited access
https://www.sciencedirect.com/science/article/abs/pii/S0145212618300778?via%3Dihub
Permanent Link: http://hdl.handle.net/11104/0297965 - 7.0191506 - UMG-J 20023088 RIV US eng J - Journal Article
Plášilová, M. - Živná, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL (Apo2L) supresses growth of primary human leukemia and myelodysplasia progenitors.
Leukemia. Roč. 16, č. 1 (2002), s. 67-73. ISSN 0887-6924. E-ISSN 1476-5551
R&D Projects: GA AV ČR IAA5052001; GA ČR GA301/99/0350
Keywords : TRAIL * leukemia * myelodysplasia
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 4.693, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087257 - 8.0191428 - UMG-J 20010500 RIV GB eng J - Journal Article
Plašilová, M. - Živný, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
Leukemia. Roč. 16, č. 1 (2002), s. 67-73. ISSN 0887-6924. E-ISSN 1476-5551
R&D Projects: GA AV ČR IAA5052001; GA ČR GA301/99/0350
Institutional research plan: CEZ:AV0Z5052915
Keywords : TRAIL * leukemia * apoptosis
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 4.693, year: 2002
Permanent Link: http://hdl.handle.net/11104/0087181 - 9.0191427 - UMG-J 20010499 RIV US eng J - Journal Article
Plašilová, M. - Živný, J. - Jelínek, J. - Neuwirtová, R. - Čermák, J. - Nečas, E. - Anděra, Ladislav - Stopka, T.
TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD3+ cell repopulation in NOD/SCID mice.
Blood. Roč. 98, č. 11 (2001), s. 3043. ISSN 0006-4971. E-ISSN 1528-0020
R&D Projects: GA AV ČR IAA5052001
Institutional research plan: CEZ:AV0Z5052915
Keywords : TRAIL * leukemia * apoptosis
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 9.273, year: 2001
Permanent Link: http://hdl.handle.net/11104/0087180